Image

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Research on PF-07275315 for moderate to severe COPD patients.

Recruiting
35-80 years
All
Phase 2/3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is about a new medicine called PF-07275315 for people with Chronic Obstructive Pulmonary Disease (COPD). COPD is a lung disease that makes it hard to breathe. The study is checking if this medicine is safe and works well.

  • Participants will either get the study medicine or a placebo, which is a fake medicine that looks real but has no effect.
  • The study has two parts: Phase 2 lasts about 40 weeks with 11 clinic visits, and Phase 3 lasts about 68 weeks with 18 visits.
  • Participants must be 35-80 years old, have moderate-to-severe COPD for at least 12 months, and have experienced at least 2 bad flare-ups in the last year.

If you join, you'll get several shots over 24 weeks in Phase 2 and over 52 weeks in Phase 3. The study will compare people taking the real medicine to those on the placebo. This helps researchers find out if the medicine is safe and effective for treating COPD.

Print
Study details
    Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT07363694

Pfizer

18 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.